Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting

This study has been completed.
Information provided by:
ZymoGenetics Identifier:
First received: August 30, 2006
Last updated: March 6, 2009
Last verified: March 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)